With reference to its communication dated December 22, 2023, whereby the Company had intimated its intention to raise funds by way of a rights issue, pursuant to a resolution of Board of Directors of the Company of the same day. Subsequently, on March 26, 2024, the Company had clarified that it was in the process of completing the necessary formalities and compliances, required for the proposed rights issue of equity shares, and that it shall make the necessary announcement(s) at the appropriate time as warranted under the applicable regulations of the Securities and Exchange Board of India. Further to the above, UPL has informed that that it has made appropriate progress in the matter and plans to make necessary announcements in compliance with the applicable regulations of the Securities and Exchange Board of India, after publication of unaudited financial results for Q2.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| UPL | 656.15 |
| PI Industries | 3036.95 |
| Bayer CropScience | 4852.90 |
| Sharda Cropchem | 1101.50 |
| Sumitomo Chemical | 446.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: